Jinarc 30 mg Tablet

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
67	多発性嚢胞腎	2

67. 多発性嚢胞腎

臨床試験数 : 221 / 薬物数 : 212 - (DrugBank : 55) / 標的遺伝子数 : 40 - 標的パスウェイ数 : 151

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-004115-39-DK (EUCTR)	08/02/2018	13/12/2017	Same as above	Subacute Effect of Tolvaptan on Total Kidney Volumen in Adult Patients with Autosomal Dominant Polyc ...	Autosomal Dominant Polycystic Kidney DIsease MedDRA version: 20.0;Level: LLT;Classification code 100 ...	Trade Name: Jinarc 15 mg tablets, Jinarc 45 mg tablets Product Name: Jinarc - Tolvaptan tablets Produc ...	Nordsjællands Hospital, Department of Cardiology, Nephrology and Endocrinology	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 4	Denmark
2	EUCTR2020-005992-10-DE (EUCTR)		26/05/2021	A trial to see if tolvaptan is safe in infants and children who at enrollment are 28 days to less th ...	A Phase 3b Multicenter Open-label Trial of the Safety, Tolerability, and Efficacy of Tolvaptan in In ...	Autosomal Recessive Polycystic Kidney Disease (ARPKD) MedDRA version: 20.0;Level: LLT;Classification ...	Trade Name: SAMSCA 7.5 mg oral tablet Product Name: Tolvaptan 7.5 mg Tablet Product Code: OPC-41061 INN ...	Otsuka Pharmaceutical Development & Commercialization, Inc.	NULL	NA			Female: yes Male: yes	10	Phase 3	United States;Belgium;Germany;United Kingdom;Italy

First Previous1Next Last